Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT
Novartis names drugs chief as CEO to deliver return to growth
Novartis CEO Jimenez to Quit, Giving Reins to Harvard Doctor - Bloomberg
What I learned in my three years as CEO
Vas Narasimhan en LinkedIn: Returning to my alma mater is always a source of energy and optimism, as… | 33 comentarios
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
Is Covid over? At HTLS, Novartis CEO Narasimhan says 'let society move forward' | Latest News India - Hindustan Times
It was never my plan to be the boss of a huge company' - BBC News
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
CEO's letter - Novartis Annual Review 2019
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Novartis CEO Steers Drug Maker Back to R&D - WSJ
Novartis CEO touts 25 potential—and diverse—blockbuster launches. But is its portfolio too scattered? | Fierce Pharma
Vasant Narasimhan – Wikipedia
Vasant Narasimhan: Biography of Vasant Narasimhan CEO of Novartis
Biotech can become a powerhouse in India': Novartis' Narasimhan | Mint
Vas Narasimhan, CEO of Swiss pharmaceutical group Novartis, speaks during the annual results media conference at the Novartis Campus in Basel, Switzerland, on Wednesday, Jan. 30, 2019. (Patrick Straub/Keystone via AP Stock
Novartis appointed Vasant Narasimhan as CEO, effective February 1, 2018
CEO Vas Narasimhan tells employees Novartis' deal with Trump lawyer was a mistake he's determined to overcome | Fierce Pharma
Vasant Narasimhan - Wikipedia
Novartis CEO Vas Narasimhan on the timeline for coronavirus treatments
Novartis Has Dropped Some Cancer Drugs From Pipeline, CEO Says | Barron's
Novartis CEO Vasant Narasimhan on China's coronavirus outbreak
